Centerline Biomedical Scoops Up $10M

Centerline Biomedical Centerline a Cleveland Clinic spinout company is announcing updates regarding its IOPS platform technology designed to improve patient and caregiver safety reduce procedure time limit harmful radiation and contrast dye and overall reduce costs to healthcare systems while improving access to care

The company has closed 10 million in funding in its first senior security offering in 2019 which will bolster key talent needs and allow for commercialization Limited launch commercialization is beginning in the second quarter of , with full launch beginning in the second half of the year Early indications from voice-of-customer feedback are that the technology fills a critical patient physician and healthcare provider need which is supported by the number of evaluations in process

To maintain this momentum Centerline is aggressively hiring key talent across the organization Newly-appointed Head of R&D Sreenivasan Sreeni Narayanan brings 25 plus years of experience in medical technology startups as well as multinationals most notably in leadership roles at Siemens Healthineers where he recently served as Senior Director of R&D Strategy in the Advanced Therapy division Sonya Snyder fills another key senior role as Head of Operations Mrs Snyder’s tremendous experience includes over 20 years in manufacturing and operations 15 of which were in the medical device sector launching more than 40 new products Trained by the Shingijutsu group in Japan she is an expert in Lean manufacturing methodologies

The closing of this financing round plus recruiting for these leadership roles bodes well for our organization and launch efforts noted Philip D Rackliffe CEO Adding best-in-class talent to a game-changing technology is the perfect mix for growing an emerging technology company with the goal of lowering healthcare costs while improving patient and healthcare safety ”

Centerline was also recently made aware that their scientific submission for the Vascular Annual Meeting VAM was accepted Cleveland Clinic vascular surgeon Dr Behzad Farivar will be presenting on Centerline research he conducted in a talk titled 3D Holographic Guidance Navigation and Control 3D-GNC for Endograft Positioning in Porcine Aorta Feasibility Comparison with 2D X-ray Fluoroscopy at this leading vascular surgery conference The research funded through a small business grant from the NIH demonstrated IOPS platform’s potential in an animal model showing significant advantages and advanced capabilities

We started Centerline with the goal of improving almost every aspect of minimally-invasive cardiovascular care remarked Vikash Goel CTO For five years our key clinician partners have provided immense support and have eagerly awaited this year’s clinical launch We could not be more excited to prove out our revolutionary technology ”

For more information please visit centerlinebiomedical com

Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Centerline%20Biomedical/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co